摘要
自1967年超声首次应用于甲状腺,经过数十年的发展,超声已成为甲状腺疾病诊断和治疗领域一线影像学方法。基于常规超声的甲状腺结节风险分层系统在甲状腺疾病诊断中发挥着举足轻重的作用。近年来,超声造影、基于甲状腺细针穿刺活检的分子诊断以及人工智能等新技术被广泛应用于甲状腺疾病超声诊断。甲状腺良恶性肿瘤的热消融治疗具有定位精准、创伤小、最大限度保留甲状腺功能等优势。相关指南共识对甲状腺疾病微创治疗操作进行规范。甲状腺科普工作进一步规范疾病诊治、提升全国甲状腺疾病治疗水平。本文就2022年中国学者在甲状腺超声领域的代表性研究进展进行述评。
After decades of development,ultrasound(US)has become the first-line imaging method in the diagnosis and treatment of thyroid diseases since US was applied in thyroid in 1967.The risk stratification system of thyroid nodules based on conventional US plays a pivotal role in the diagnosis of thyroid diseases.In recent years,contrasted-enhanced US(CEUS),molecular diagnosis based on thyroid fine-needle aspiration biopsy and artificial intelligence have been widely used in thyroid diseases diagnosis.Thermal ablation of thyroid tumors has played the advantages of precise positioning,less trauma and maximum preservation of thyroid function.The relevant guideline consensuses regulate the minimally invasive treatment operation of thyroid diseases.Thyroid science popularization will further standardize the diagnosis and treatment of diseases and improve the treatment level of nationwide.This review summarized the representative research progress in the field of thyroid US in 2022.
作者
张颖
张一峰
徐辉雄
ZHANG Ying;ZHANG Yifeng;XU Huixiong(Department of Medical Ultrasound,Shanghai Tenth Peoples Hospital,Tongji University,Shanghai 200072,China;Department of Ultrasound,Zhongshan Hospital,Fudan University,Shanghai 200032,China)
出处
《肿瘤影像学》
2023年第5期472-477,共6页
Oncoradiology
基金
国家自然科学基金面上项目(82171942)。
关键词
甲状腺
超声
诊断
微创治疗
人工智能
Thyroid
Ultrasound
Diagnosis
Minimally invasive therapy
Artificial intelligence
